Article Cited by others

INVITED REVIEW

Testosterone and benign prostatic hyperplasia

Jarvis Thomas R, Chughtai Bilal, Kaplan Steven A

Year : 2015| Volume: 17| Issue : 2 | Page no: 212-216

   This article has been cited by
 
1 Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy
Antonio B. Porcaro,Alessandro Tafuri,Marco Sebben,Giovanni Novella,Tania Processali,Marco Pirozzi,Nelia Amigoni,Riccardo Rizzetto,Aliasger Shakir,Arianna Mariotto,Matteo Brunelli,Maria Angela Cerruto,Giovanni Enrico Cacciamani,Filippo Migliorini,Salvatore Siracusano,Walter Artibani
World Journal of Urology. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 Sex hormones and oxidative stress mediated phthalate-induced effects in prostatic enlargement
Wei-Hsiang Chang,Yuh-Shyan Tsai,Jia-Yu Wang,Hsiu-Ling Chen,Wen-Horng Yang,Ching-Chang Lee
Environment International. 2019; 126: 184
[Pubmed]  [Google Scholar] [DOI]
3 “Prostate telocytes change their phenotype in response to castration or testosterone replacement”
Sérgio Luis Felisbino,Bruno Domingos Azevedo Sanches,Flávia Karina Delella,Wellerson Rodrigo Scarano,Fernanda Cristina Alcântara Dos Santos,Patrícia Simone Leite Vilamaior,Sebastião Roberto Taboga,Luis Antônio Justulin
Scientific Reports. 2019; 9(1)
[Pubmed]  [Google Scholar] [DOI]
4 The association between body mass index and testosterone deficiency in aging Chinese men with benign prostatic hyperplasia: results from a cross-sectional study
Yu Wu,Ding Xu,Hai-Bo Shen,Su-Bo Qian,Jun Qi,Xu-Jun Sheng
The Aging Male. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Obesity’s role in secondary male hypogonadism: a review of pathophysiology and management issues
Omar Seyam,Jason Gandhi,Gunjan Joshi,Noel L. Smith,Sardar Ali Khan
SN Comprehensive Clinical Medicine. 2019;
[Pubmed]  [Google Scholar] [DOI]
6 Association between the symptoms of benign prostatic hyperplasia and social disparities: Does social capital promote prostate health?
Myung-Bae Park,Dae Sung Hyun,Jae Mann Song,Hyun Chul Chung,Sung Won Kwon,Sae Chul Kim,Chhabi Lal Ranabhat,Tae Sic Lee,Sang-Baek Koh
Andrologia. 2018; : e13125
[Pubmed]  [Google Scholar] [DOI]
7 Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach
Adriana Albini,Antonino Bruno,Barbara Bassani,Gioacchino D’Ambrosio,Giuseppe Pelosi,Paolo Consonni,Laura Castellani,Matteo Conti,Simone Cristoni,Douglas M. Noonan
Frontiers in Endocrinology. 2018; 9
[Pubmed]  [Google Scholar] [DOI]
8 Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats
Oluwatosin Adekunle Adaramoye,Olubukola Oyebimpe Akanni,Olusoji John Abiola,Solomon Eduviere Owumi,Oluyemi Akinloye,Emiola Olubunmi Olapade-olaopa
Biomedicine & Pharmacotherapy. 2017; 95: 1493
[Pubmed]  [Google Scholar] [DOI]
9 Withania coagulans Extract Induces Cell Apoptosis and Inhibits COX-2 Expression in a Rat Model of Benign Prostatic Hyperplasia
Maryam Sarbishegi,Ozra Khajavi,Mohammad Reza Arab
Nephro-Urology Monthly. 2016; Inpress(Inpress)
[Pubmed]  [Google Scholar] [DOI]
10 Testosterone Replacement Therapy on the Natural History of Prostate Disease
Aaron Moore,Michael J. Butcher,Tobias S. Köhler
Current Urology Reports. 2015; 16(8)
[Pubmed]  [Google Scholar] [DOI]
11 Controversies in testosterone supplementation therapy
Mohit Khera
Asian Journal of Andrology. 2015; 17(2): 175
[Pubmed]  [Google Scholar] [DOI]

 

Read this article